JAMIE HANOSH: Open Payments
NPI 1497471197 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 70 payments from 27 companies in 2025. Trend: 2023 $792 · 2024 $916 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $275 |
| Edwards Lifesciences Corporation | 2 | $271 |
| PFIZER INC. | 13 | $203 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| Novo Nordisk Inc | 4 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Alkermes, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
Products named: SAPIEN 3 Ultra RESILIA, NURTEC ODT, UBRELVY, VRAYLAR, QULIPTA, CAPLYTA, VIVITROL, ZENPEP.
Industry payments across CO — which companies pay providers there.
